Rewriting Renal Fate: The Evolving Landscape of Adeno-Associated Virus-Mediated Kidney Gene Therapies.
Publication
, Journal Article
Hickman, PG; Asokan, A; Wilson, MH
Published in: Kidney360
February 1, 2026
Duke Scholars
Published In
Kidney360
DOI
EISSN
2641-7650
Publication Date
February 1, 2026
Volume
7
Issue
2
Start / End Page
422 / 425
Location
United States
Related Subject Headings
- 4202 Epidemiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hickman, P. G., Asokan, A., & Wilson, M. H. (2026). Rewriting Renal Fate: The Evolving Landscape of Adeno-Associated Virus-Mediated Kidney Gene Therapies. Kidney360, 7(2), 422–425. https://doi.org/10.34067/KID.0000001119
Hickman, Peyton G., Aravind Asokan, and Matthew H. Wilson. “Rewriting Renal Fate: The Evolving Landscape of Adeno-Associated Virus-Mediated Kidney Gene Therapies.” Kidney360 7, no. 2 (February 1, 2026): 422–25. https://doi.org/10.34067/KID.0000001119.
Hickman PG, Asokan A, Wilson MH. Rewriting Renal Fate: The Evolving Landscape of Adeno-Associated Virus-Mediated Kidney Gene Therapies. Kidney360. 2026 Feb 1;7(2):422–5.
Hickman, Peyton G., et al. “Rewriting Renal Fate: The Evolving Landscape of Adeno-Associated Virus-Mediated Kidney Gene Therapies.” Kidney360, vol. 7, no. 2, Feb. 2026, pp. 422–25. Pubmed, doi:10.34067/KID.0000001119.
Hickman PG, Asokan A, Wilson MH. Rewriting Renal Fate: The Evolving Landscape of Adeno-Associated Virus-Mediated Kidney Gene Therapies. Kidney360. 2026 Feb 1;7(2):422–425.
Published In
Kidney360
DOI
EISSN
2641-7650
Publication Date
February 1, 2026
Volume
7
Issue
2
Start / End Page
422 / 425
Location
United States
Related Subject Headings
- 4202 Epidemiology
- 3202 Clinical sciences